EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-5.65%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.02B
AUM Growth
+$1.02B
(-5.8%)
Cap. Flow
+$84.8M
Cap. Flow
% of AUM
8.28%
Top 10 Holdings %
Top 10 Hldgs %
54.92%
Holding
96
New
13
Increased
32
Reduced
16
Closed
24
Top Buys
| 1 |
Sanofi
SNY
|
$44M |
| 2 |
SPDR S&P Biotech ETF
XBI
|
$26.4M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$22.3M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$19.1M |
| 5 |
AstraZeneca
AZN
|
$18.2M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$49M |
| 2 |
HCA Healthcare
HCA
|
$27.9M |
| 3 |
Masimo
MASI
|
$26.5M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
$21.6M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$16.2M |
Sector Composition
| 1 | Healthcare | 95.7% |
| 2 | Industrials | 1.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Xenon Pharmaceuticals
XENE
$3.03B
| $14.2M | 1.01% |
465,911
+55,890
| +14% | +$1.7M |
|
|
RCM
27
DELISTED
R1 RCM Inc. Common Stock
RCM
| $12.4M | 0.88% |
590,819
-770,687
| -57% | -$16.2M |
|
28
Maravai LifeSciences
MRVI
$340M
| $12.1M | 0.86% |
+425,364
| New | +$12.1M |
|
29
Lantheus
LNTH
$3.77B
| $11.9M | 0.85% |
+180,053
| New | +$11.9M |
|
30
Alnylam Pharmaceuticals
ALNY
$59.1B
| $11.5M | 0.82% |
78,987
+26,116
| +49% | +$3.81M |
|
31
908 Devices
MASS
$204M
| $9.69M | 0.69% |
470,444
+253,295
| +117% | +$5.22M |
|
32
Liquidia Corp
LQDA
$2.54B
| $9.15M | 0.65% |
2,099,708
+722,218
| +52% | +$3.15M |
|
33
Qiagen
QGEN
$10.1B
| $8.96M | 0.64% |
189,907
-2,792
| -1% | -$132K |
|
|
TARO
34
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $7.97M | 0.57% |
220,390
+104
| +0% | +$3.76K |
|
35
HealthEquity
HQY
$8B
| $7.8M | 0.55% |
127,043
-17,097
| -12% | -$1.05M |
|
36
Merus
MRUS
$5.06B
| $6.52M | 0.46% |
287,806
+210,957
| +275% | +$4.78M |
|
37
Illumina
ILMN
$15.4B
| $6.5M | 0.46% |
35,266
-3,493
| -9% | -$644K |
|
38
Humana
HUM
$37.2B
| $5.24M | 0.37% |
+11,170
| New | +$5.24M |
|
|
RDUS
39
DELISTED
Radius Health, Inc.
RDUS
| $5.21M | 0.37% |
502,587
+200,415
| +66% | +$2.08M |
|
40
Viridian Therapeutics
VRDN
$1.58B
| $5.16M | 0.37% |
445,592
+289,849
| +186% | +$3.35M |
|
41
Amicus Therapeutics
FOLD
$2.43B
| $5.14M | 0.37% |
+478,245
| New | +$5.14M |
|
42
Puma Biotechnology
PBYI
$265M
| $4.09M | 0.29% |
1,435,077
+10,427
| +0.7% | +$29.7K |
|
43
Gossamer Bio
GOSS
$596M
| $3.92M | 0.28% |
468,303
+93,580
| +25% | +$783K |
|
44
AnaptysBio
ANAB
$594M
| $3.71M | 0.26% |
182,717
+68,552
| +60% | +$1.39M |
|
45
Ionis Pharmaceuticals
IONS
$9.73B
| $3.2M | 0.23% |
86,311
-72,495
| -46% | -$2.68M |
|
|
AFMD
46
DELISTED
Affimed
AFMD
| $3.13M | 0.22% |
+1,130,761
| New | +$3.13M |
|
47
Agilent Technologies
A
$35.3B
| $2.41M | 0.17% |
20,264
+1,009
| +5% | +$120K |
|
48
Intuitive Surgical
ISRG
$166B
| $1.72M | 0.12% |
8,591
+428
| +5% | +$85.9K |
|
49
Revvity
RVTY
$9.78B
| $1.46M | 0.1% |
10,293
+505
| +5% | +$71.8K |
|
50
IQVIA
IQV
$31B
| $1.31M | 0.09% |
6,024
-53,546
| -90% | -$11.6M |
|